EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma

Bailu Yang iD, Fukai Wen, Yifeng Cui

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Bailu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Gene Expression Regulation, Neoplastic, Gene Expression Profiling. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Heilongjiang Postdoctoral Science Foundation, The Scientifc Foundation of the First Affiliated Hospital of Harbin Medical University, Excellent Youth Science Fund of the First Affiliated Hospital of Harbin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) stands as the most prevalent and treatment‐resistant malignant tumour, characterized by a dismal prognosis. Croton acylation (CA) has recently gained attention as a critical factor in cancer pathogenesis. This study sought to rapidly identify prognostic features of HCC linked to CA. Differential analysis was conducted between tumour tissues and adjacent non‐tumour tissues in the TCGA‐LIHC and GSE76427 datasets to uncover differentially expressed genes (DEG1 and DEG2). The intersection of DEG1 and DEG2 highlighted DEGs with consistent expression patterns. Single‐sample gene set enrichment analysis scores were calculated for 18 lysine crotonylation‐related genes (LCRGs) identified in prior research, showing significant differences between tumour and normal groups. Subsequently, weighted gene co‐expression network analysis was employed to identify key module genes correlated with the LCRG score. Candidate genes were identified by overlapping consistently expressed DEGs with key module genes. Prognostic features were identified, and risk scores were determined via regression analysis. Patients were categorized into risk groups based on the optimal cutoff value. Gene set enrichment analysis (GSEA) and immunoassays were also performed. The prognostic features were further validated using reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR). A total of 88 candidate genes were identified from 1179 consistently expressed DEGs and 4200 key module genes. Seven prognostic features were subsequently identified: TMCO3, RAP2A, ITGAV, ZFYVE26, CHST9, HMGN4, and KLHL21. GSEA revealed that DEGs between risk groups were primarily associated with chylomicron metabolism, among other pathways. Additionally, activated CD4+ T cells demonstrated the strongest positive correlation with risk scores, and most immune checkpoints showed significant differences between risk groups, with ASXL1 exhibiting the strongest correlation with risk scores. The Tumour Immune Dysfunction and Exclusion score was notably higher in the high‐risk group. Moreover, in both the TCGA‐LIHC and ICGC‐LIRI‐JP datasets, the expression of other prognostic features was elevated in tumour tissues, with the exception of CHST9. RT‐qPCR confirmed the increased expression of TMCO3, RAP2A, ITGAV, ZFYVE26, and HMGN4. This study establishes a risk model for HCC based on seven crotonylation‐associated prognostic features, offering a theoretical framework for the diagnosis and treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsGene Expression Regulation, NeoplasticGene Expression ProfilingBiomarkers, TumorTranscriptomeHumansPrognosisFemaleGene Regulatory NetworksMaleMiddle AgedDrug Resistance, Neoplasm

Stichwörter der Autor:innen

hepatocellular carcinomalysine crotonylation‐related genesprognostic characteristicsrisk module

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

ORCID-Profile: Bailu Yang

Förderung

  • The Heilongjiang Postdoctoral Science Foundation
  • The Scientifc Foundation of the First Affiliated Hospital of Harbin Medical University
  • Excellent Youth Science Fund of the First Affiliated Hospital of Harbin Medical University
  • Heilongjiang Provincial Postdoctoral Science Foundation

Zitieren

APA

Yang, B., Wen, F., & Cui, Y. (2024). Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70083

Vancouver

Yang B, Wen F, Cui Y. Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70083

BibTeX
@article{Yang2024,
  author = {Yang, Bailu and Wen, Fukai and Cui, Yifeng},
  title = {Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70083}
}
Kostenlos starten →